ALPS Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-31,910
| Closed | -$294K | – | 803 |
|
|
2017
Q1 | $294K | Sell |
31,910
-3,735
| -10% | -$34.4K | ﹤0.01% | 695 |
|
|
2016
Q4 | $275K | Sell |
35,645
-10,102
| -22% | -$77.9K | ﹤0.01% | 677 |
|
|
2016
Q3 | $523K | Buy |
45,747
+3,185
| +7% | +$36.4K | ﹤0.01% | 263 |
|
|
2016
Q2 | $524K | Buy |
42,562
+8,701
| +26% | +$107K | ﹤0.01% | 248 |
|
|
2016
Q1 | $342K | Sell |
33,861
-5,802
| -15% | -$58.6K | ﹤0.01% | 576 |
|
|
2015
Q4 | $894K | Sell |
39,663
-7,323
| -16% | -$165K | 0.01% | 220 |
|
|
2015
Q3 | $7.8K | Buy |
46,986
+17,206
| +58% | +$2.85K | 0.01% | 223 |
|
|
2015
Q2 | $670K | Buy |
29,780
+14,958
| +101% | +$337K | 0.01% | 246 |
|
|
2015
Q1 | $382K | Buy |
+14,822
| New | +$382K | ﹤0.01% | 617 |
|